Strategic Wealth Partners, Ltd.

Position in GILD — Gilead Sciences, Inc.

CIK 1720777 INDEPENDENCE, OH

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$25,899

-$5,041 QoQ

Shares Held

205

-7.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#2,118

of 2,266 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Strategic Wealth Partners, Ltd. holds $59,561,760 across 15 Drug Manufacturers - General names. GILD ranks #11 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	15,389	$18,458,029
2	AZN	Astrazeneca PLC	88,890	$16,855,321
3	ABBV	AbbVie Inc.	63,589	$16,001,535
4	AMGN	Amgen Inc	12,495	$4,524,689
5	MRK	Merck & Co., Inc.	12,974	$1,667,159
6	JNJ	Johnson & Johnson	5,276	$1,339,945
7	BMY	Bristol Myers Squibb Co	4,957	$285,622
8	NVS	Novartis AG	1,133	$177,563

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,899	205	-7.7%	Shares	Sole	2026-08-12
2026-03-31	$30,940	222	+3.3%	Shares	Sole	2026-05-12
2025-12-31	$26,389	215	-18.6%	Shares	Sole	2026-05-12
2025-09-30	$29,304	264	0.0%	Shares	Sole	2025-11-14
2025-06-30	$29,269	264	-96.7%	Shares	Sole	2025-08-11
2023-12-31	$644,029	7,950	-74.7%	Shares	Sole	2024-05-20
2023-09-30	$2,359,410	31,484	-10.2%	Shares	Sole	2024-05-20
2023-06-30	$2,702,844	35,070	-2.0%	Shares	Sole	2024-05-20
2023-03-31	$2,968,500	35,778	-2.8%	Shares	Sole	2023-04-24
2022-12-31	$3,160,310	36,812	-46.9%	Shares	Sole	2023-04-24
2022-09-30	$4,275,548	69,307	-0.6%	Shares	Sole	2023-04-24
2022-06-30	$4,309,269	69,718	-2.9%	Shares	Sole	2022-08-22
2022-03-31	$4,266,667	71,769	-6.5%	Shares	Sole	2022-05-19
2021-12-31	$5,575,358	76,785	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.